Shopping Cart 0
Cart Subtotal
AED 0

Global qPCR and dPCR Market Forecast up to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 10093

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 12845

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 16515

Details

Global qPCR and dPCR Market 2019-2025

[93 pages report] This market research report includes a detailed segmentation of the global qPCR and dPCR market-By Technology Type (qPCR and dPCR), By Product Type (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Biomedical Research, and Others), By End Users (Hospitals & Laboratories, Pharmaceutical Companies, Academics, and Others), By Region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global qPCR and dPCR Market Research

Infoholic's market research report predicts that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.

 

 

The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-user's perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.

According to Infoholic Research analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.

By Product Type:

Instruments

Reagents and Consumables

Software and Services

In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.

By Applications:

Clinical Diagnostics

Biomedical Research

Others

In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.

By Technology Type:

Qualitative PCR

Digital PCR

qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.

By End Users:

Hospitals and Laboratories

Pharmaceutical Companies

Academics

Others

In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.

qPCR and dPCR Market Research Competitive Analysis-The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn't signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.

Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around USD 5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.

Key vendors:

Thermo Fisher Scientific

Bio-Rad Laboratories

Danaher Corp.

Agilent Technologies, Inc.

Qiagen N.V.

F. Hoffmann-La Roche

Abbott Laboratories

Promega Corp.

Eppendorf AG

BioMerieux S.A.

Merck KGaA

Key competitive facts -

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.

The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.

Benefits-The report provides complete details about the usage and adoption rate of qPCR and dPCR market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of qPCR and dPCR industry

Factors influencing the growth of qPCR and dPCR market

In-depth competitive analysis of dominant and pure play vendors

Prediction analysis of qPCR and dPCR industry in both developed and developing regions

Key insights related to major segments of the qPCR and dPCR market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

 

 

READ MORE

Table Of Content

Scope

Global qPCR and dPCR Market 2019-2025

[93 pages report] This market research report includes a detailed segmentation of the global qPCR and dPCR market-By Technology Type (qPCR and dPCR), By Product Type (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Biomedical Research, and Others), By End Users (Hospitals & Laboratories, Pharmaceutical Companies, Academics, and Others), By Region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global qPCR and dPCR Market Research

Infoholic's market research report predicts that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.

 

 

The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-user's perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.

According to Infoholic Research analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.

By Product Type:

Instruments

Reagents and Consumables

Software and Services

In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.

By Applications:

Clinical Diagnostics

Biomedical Research

Others

In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.

By Technology Type:

Qualitative PCR

Digital PCR

qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.

By End Users:

Hospitals and Laboratories

Pharmaceutical Companies

Academics

Others

In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.

qPCR and dPCR Market Research Competitive Analysis-The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn't signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.

Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around USD 5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.

Key vendors:

Thermo Fisher Scientific

Bio-Rad Laboratories

Danaher Corp.

Agilent Technologies, Inc.

Qiagen N.V.

F. Hoffmann-La Roche

Abbott Laboratories

Promega Corp.

Eppendorf AG

BioMerieux S.A.

Merck KGaA

Key competitive facts -

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.

The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.

Benefits-The report provides complete details about the usage and adoption rate of qPCR and dPCR market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of qPCR and dPCR industry

Factors influencing the growth of qPCR and dPCR market

In-depth competitive analysis of dominant and pure play vendors

Prediction analysis of qPCR and dPCR industry in both developed and developing regions

Key insights related to major segments of the qPCR and dPCR market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

 

 


List Of Figure

Charts

 

CHART 1 RESEARCH METHODOLOGY OF GLOBAL QPCR AND DPCR MARKET 14

DIGITAL PCR 17

REAL-TIME PCR 17

CHART 2 GLOBAL QPCR AND DPCR MARKET REVENUE, 2018-2025 (USD MILLION) 18

CHART 3 PORTERS 5 FORCES ON GLOBAL QPCR AND DPCR MARKET 22

CHART 5 GLOBAL QPCR AND DPCR MARKET SEGMENTATION 26

CHART 6 MARKET DYNAMICS-DRIVERS, RESTRAINTS & OPPORTUNITIES 26

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL QPCR AND DPCR MARKET 30

CHART 8 KEY STAKEHOLDERS OF GLOBAL QPCR AND DPCR MARKET 31

CHART 9 GLOBAL QPCR AND DPCR MARKET SEGMENT REVENUE BY TECHNOLOGY TYPE, 2018 VS 2025 (USD MILLION) 32

CHART 10 DIGITAL PCR INSTRUMENT MARKET REVENUE, BY TYPES 2018-2025 (USD MILLION) 34

CHART 11 REAL TIME/QUANTITATIVE PCR INSTRUMENT MARKET REVENUE, BY TYPES 2018-2025 (USD MILLION) 35

CHART 12 QPCR AND DPCR MARKET SEGMENT REVENUE BY PRODUCT TYPE, 2018 VS 2025 (USD MILLION) 36

CHART 13 QPCR AND DPCR INSTRUMENT MARKET REVENUE, BY PRODUCT TYPES 2018-2025 (USD MILLION) 37

CHART 14 QPCR AND DPCR REAGENTS AND CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE 2018-2025 (USD MILLION) 39

CHART 15 QPCR AND DPCR SOFTWARE AND SERVICES MARKET REVENUE, BY PRODUCT TYPE 2018-2025 (USD MILLION) 40

CHART 16 QPCR AND DPCR MARKET SEGMENT REVENUE BY APPLICATION TYPES, 2018 (%) 41

CHART 17 GLOBAL QPCR AND DPCR MARKET SEGMENT REVENUE BY END USERS, 2018 (%) 43

CHART 18 QPCR AND DPCR MARKET BY REGIONAL SEGMENTATION, 2018 VS 2025 (USD MILLION) 46

CHART 19 QPCR AND DPCR MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 47

CHART 20 QPCR AND DPCR MARKET REVENUE IN EUROPE, 2018-2025 (USD MILLION) 49

CHART 21 QPCR AND DPCR MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 50

CHART 22 QPCR AND DPCR REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 51

CHART 23 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 59

CHART 24 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS 59

CHART 25 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHIC REVENUE 60

CHART 26 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 62

CHART 27 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 63

CHART 28 F. HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 64

CHART 29 F. HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 65

CHART 30 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 66

CHART 31 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 70

CHART 32 ABBOTT LABORATORIES: BUSINESS UNITS 70

CHART 33 ABBOTT LABORATORIES: GEOGRAPHIC REVENUE 72

CHART 34 ABBOTT LABORATORIES: SWOT ANALYSIS 73

CHART 35 QIAGEN N.V.: OVERVIEW SNAPSHOT 77

CHART 36 QIAGEN N.V.: BUSINESS UNITS 77

CHART 37 QIAGEN N.V.: GEOGRAPHIC REVENUE 78

CHART 38 QIAGEN N.V.: SWOT ANALYSIS 79

CHART 39 BIO-RAD LABORATORIES: OVERVIEW SNAPSHOT 82

CHART 40 BIO-RAD LABORATORIES: BUSINESS UNITS 82

CHART 41 BIO-RAD LABORATORIES: GEOGRAPHIC REVENUE 83

CHART 42 BIO-RAD LABORATORIES: SWOT ANALYSIS 84

 


List Of Table

Tables

 

TABLE 1 GLOBAL QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 31

TABLE 2 QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 35

TABLE 3 GLOBAL QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 46

TABLE 4 SUITABILITY OF DPCR AND QPCR FOR MAJOR APPLICATIONS 52

TABLE 5 OTHER PROMINENT VENDORS 53

TABLE 6 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 55

TABLE 7 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 56

TABLE 8 F. HOFFMANN-LA ROCHE LTD.: PRODUCT OFFERINGS 62

TABLE 9 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 62

TABLE 10 ABBOTT LABORATORIES: PRODUCT OFFERINGS 67

TABLE 11 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 67

TABLE 12 QIAGEN N.V.: OFFERINGS 73

TABLE 13 QIAGEN N.V.: RECENT DEVELOPMENTS 74

TABLE 14 BIO-RAD LABORATORIES: OFFERINGS 79

TABLE 15 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 80

TABLE 16 AGILENT TECHNOLOGIES INC.: SNAPSHOT 85

TABLE 17 AGILENT TECHNOLOGIES INC.: RECENT DEVELOPMENTS 86

TABLE 18 PROMEGA CORP.: OVERVIEW 88

TABLE 19 PROMEGA CORP.: RECENT DEVELOPMENTS 88

TABLE 20 EPPENDORF AG: OVERVIEW 89

TABLE 21 EPPENDORF AG.: RECENT DEVELOPMENTS 89

TABLE 22 BIOMERIEUX S.A.: SNAPSHOT 90

TABLE 23 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 90

TABLE 24 MERCK KGAA: OVERVIEW 92

TABLE 25 MERCK KGAA.: RECENT DEVELOPMENTS 92

TABLE 26 DANAHER CORP.: OVERVIEW 93

TABLE 27 DANAHER CORP.: RECENT DEVELOPMENTS 94

 

?

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Thermo Fisher Scientific

Bio-Rad Laboratories

Danaher Corp.

Agilent Technologies, Inc.

Qiagen N.V.

Hoffmann-La Roche

Abbott Laboratories

Promega Corp.

Eppendorf AG

BioMerieux S.A.

Merck KGaA

Company Profile

Company Profile Title

Global qPCR and dPCR Market 2019-2025

[93 pages report] This market research report includes a detailed segmentation of the global qPCR and dPCR market-By Technology Type (qPCR and dPCR), By Product Type (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Biomedical Research, and Others), By End Users (Hospitals & Laboratories, Pharmaceutical Companies, Academics, and Others), By Region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global qPCR and dPCR Market Research

Infoholic's market research report predicts that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.

 

 

The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-user's perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.

According to Infoholic Research analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.

By Product Type:

Instruments

Reagents and Consumables

Software and Services

In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.

By Applications:

Clinical Diagnostics

Biomedical Research

Others

In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.

By Technology Type:

Qualitative PCR

Digital PCR

qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.

By End Users:

Hospitals and Laboratories

Pharmaceutical Companies

Academics

Others

In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.

qPCR and dPCR Market Research Competitive Analysis-The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn't signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.

Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around USD 5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.

Key vendors:

Thermo Fisher Scientific

Bio-Rad Laboratories

Danaher Corp.

Agilent Technologies, Inc.

Qiagen N.V.

F. Hoffmann-La Roche

Abbott Laboratories

Promega Corp.

Eppendorf AG

BioMerieux S.A.

Merck KGaA

Key competitive facts -

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.

The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.

Benefits-The report provides complete details about the usage and adoption rate of qPCR and dPCR market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of qPCR and dPCR industry

Factors influencing the growth of qPCR and dPCR market

In-depth competitive analysis of dominant and pure play vendors

Prediction analysis of qPCR and dPCR industry in both developed and developing regions

Key insights related to major segments of the qPCR and dPCR market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

 

 

READ MORE

Scope

Global qPCR and dPCR Market 2019-2025

[93 pages report] This market research report includes a detailed segmentation of the global qPCR and dPCR market-By Technology Type (qPCR and dPCR), By Product Type (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical Diagnostics, Biomedical Research, and Others), By End Users (Hospitals & Laboratories, Pharmaceutical Companies, Academics, and Others), By Region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global qPCR and dPCR Market Research

Infoholic's market research report predicts that the global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.

 

 

The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-user's perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.

According to Infoholic Research analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.

By Product Type:

Instruments

Reagents and Consumables

Software and Services

In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.

By Applications:

Clinical Diagnostics

Biomedical Research

Others

In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.

By Technology Type:

Qualitative PCR

Digital PCR

qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.

By End Users:

Hospitals and Laboratories

Pharmaceutical Companies

Academics

Others

In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.

By Regions:

North America

Europe

APAC

ROW

The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.

qPCR and dPCR Market Research Competitive Analysis-The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn't signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.

Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around USD 5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.

Key vendors:

Thermo Fisher Scientific

Bio-Rad Laboratories

Danaher Corp.

Agilent Technologies, Inc.

Qiagen N.V.

F. Hoffmann-La Roche

Abbott Laboratories

Promega Corp.

Eppendorf AG

BioMerieux S.A.

Merck KGaA

Key competitive facts -

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.

The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.

Benefits-The report provides complete details about the usage and adoption rate of qPCR and dPCR market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

Understanding the potential market opportunity with precise market size and forecast data

Detailed market analysis focusing on the growth of qPCR and dPCR industry

Factors influencing the growth of qPCR and dPCR market

In-depth competitive analysis of dominant and pure play vendors

Prediction analysis of qPCR and dPCR industry in both developed and developing regions

Key insights related to major segments of the qPCR and dPCR market

Latest market trend analysis impacting the buying behavior of the consumers

 

Key Stakeholders -

 

 

 

 


List Of Figure

Charts

 

CHART 1 RESEARCH METHODOLOGY OF GLOBAL QPCR AND DPCR MARKET 14

DIGITAL PCR 17

REAL-TIME PCR 17

CHART 2 GLOBAL QPCR AND DPCR MARKET REVENUE, 2018-2025 (USD MILLION) 18

CHART 3 PORTERS 5 FORCES ON GLOBAL QPCR AND DPCR MARKET 22

CHART 5 GLOBAL QPCR AND DPCR MARKET SEGMENTATION 26

CHART 6 MARKET DYNAMICS-DRIVERS, RESTRAINTS & OPPORTUNITIES 26

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL QPCR AND DPCR MARKET 30

CHART 8 KEY STAKEHOLDERS OF GLOBAL QPCR AND DPCR MARKET 31

CHART 9 GLOBAL QPCR AND DPCR MARKET SEGMENT REVENUE BY TECHNOLOGY TYPE, 2018 VS 2025 (USD MILLION) 32

CHART 10 DIGITAL PCR INSTRUMENT MARKET REVENUE, BY TYPES 2018-2025 (USD MILLION) 34

CHART 11 REAL TIME/QUANTITATIVE PCR INSTRUMENT MARKET REVENUE, BY TYPES 2018-2025 (USD MILLION) 35

CHART 12 QPCR AND DPCR MARKET SEGMENT REVENUE BY PRODUCT TYPE, 2018 VS 2025 (USD MILLION) 36

CHART 13 QPCR AND DPCR INSTRUMENT MARKET REVENUE, BY PRODUCT TYPES 2018-2025 (USD MILLION) 37

CHART 14 QPCR AND DPCR REAGENTS AND CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE 2018-2025 (USD MILLION) 39

CHART 15 QPCR AND DPCR SOFTWARE AND SERVICES MARKET REVENUE, BY PRODUCT TYPE 2018-2025 (USD MILLION) 40

CHART 16 QPCR AND DPCR MARKET SEGMENT REVENUE BY APPLICATION TYPES, 2018 (%) 41

CHART 17 GLOBAL QPCR AND DPCR MARKET SEGMENT REVENUE BY END USERS, 2018 (%) 43

CHART 18 QPCR AND DPCR MARKET BY REGIONAL SEGMENTATION, 2018 VS 2025 (USD MILLION) 46

CHART 19 QPCR AND DPCR MARKET REVENUE IN NORTH AMERICA, 2018-2025 (USD MILLION) 47

CHART 20 QPCR AND DPCR MARKET REVENUE IN EUROPE, 2018-2025 (USD MILLION) 49

CHART 21 QPCR AND DPCR MARKET REVENUE IN ASIA PACIFIC, 2018-2025 (USD MILLION) 50

CHART 22 QPCR AND DPCR REVENUE IN REST OF THE WORLD, 2018-2025 (USD MILLION) 51

CHART 23 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 59

CHART 24 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS 59

CHART 25 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHIC REVENUE 60

CHART 26 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 62

CHART 27 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 63

CHART 28 F. HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 64

CHART 29 F. HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 65

CHART 30 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 66

CHART 31 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 70

CHART 32 ABBOTT LABORATORIES: BUSINESS UNITS 70

CHART 33 ABBOTT LABORATORIES: GEOGRAPHIC REVENUE 72

CHART 34 ABBOTT LABORATORIES: SWOT ANALYSIS 73

CHART 35 QIAGEN N.V.: OVERVIEW SNAPSHOT 77

CHART 36 QIAGEN N.V.: BUSINESS UNITS 77

CHART 37 QIAGEN N.V.: GEOGRAPHIC REVENUE 78

CHART 38 QIAGEN N.V.: SWOT ANALYSIS 79

CHART 39 BIO-RAD LABORATORIES: OVERVIEW SNAPSHOT 82

CHART 40 BIO-RAD LABORATORIES: BUSINESS UNITS 82

CHART 41 BIO-RAD LABORATORIES: GEOGRAPHIC REVENUE 83

CHART 42 BIO-RAD LABORATORIES: SWOT ANALYSIS 84

 


List Of Table

Tables

 

TABLE 1 GLOBAL QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 31

TABLE 2 QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 35

TABLE 3 GLOBAL QPCR AND DPCR MARKET REVENUE, BY PRODUCT TYPE, 2018-2025 (USD MILLION) 46

TABLE 4 SUITABILITY OF DPCR AND QPCR FOR MAJOR APPLICATIONS 52

TABLE 5 OTHER PROMINENT VENDORS 53

TABLE 6 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 55

TABLE 7 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 56

TABLE 8 F. HOFFMANN-LA ROCHE LTD.: PRODUCT OFFERINGS 62

TABLE 9 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 62

TABLE 10 ABBOTT LABORATORIES: PRODUCT OFFERINGS 67

TABLE 11 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 67

TABLE 12 QIAGEN N.V.: OFFERINGS 73

TABLE 13 QIAGEN N.V.: RECENT DEVELOPMENTS 74

TABLE 14 BIO-RAD LABORATORIES: OFFERINGS 79

TABLE 15 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 80

TABLE 16 AGILENT TECHNOLOGIES INC.: SNAPSHOT 85

TABLE 17 AGILENT TECHNOLOGIES INC.: RECENT DEVELOPMENTS 86

TABLE 18 PROMEGA CORP.: OVERVIEW 88

TABLE 19 PROMEGA CORP.: RECENT DEVELOPMENTS 88

TABLE 20 EPPENDORF AG: OVERVIEW 89

TABLE 21 EPPENDORF AG.: RECENT DEVELOPMENTS 89

TABLE 22 BIOMERIEUX S.A.: SNAPSHOT 90

TABLE 23 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 90

TABLE 24 MERCK KGAA: OVERVIEW 92

TABLE 25 MERCK KGAA.: RECENT DEVELOPMENTS 92

TABLE 26 DANAHER CORP.: OVERVIEW 93

TABLE 27 DANAHER CORP.: RECENT DEVELOPMENTS 94

 

?

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Thermo Fisher Scientific

Bio-Rad Laboratories

Danaher Corp.

Agilent Technologies, Inc.

Qiagen N.V.

Hoffmann-La Roche

Abbott Laboratories

Promega Corp.

Eppendorf AG

BioMerieux S.A.

Merck KGaA